- Nanoparticle-Based Chimeric Antigen Receptor Therapy for Cancer Immunotherapy
-
Shin S, Lee P, Han J, Kim SN, Lim J, Park DH, Paik T, Min J, Park CG, Park W
- KMID: 2542958
- Tissue Eng Regen Med.
- 2023 Jun;20(3):371-387.
- doi: 10.1007/s13770-022-00515-8
Adoptive cell therapy with chimeric antigen receptor (CAR)-engineered T cells (CAR-Ts) has emerged as an innovative immunotherapy for hematological cancer treatment. However, the limited effect on solid tumors, complex processes,... -
- CITED
-
- Close
- SHARE
-
- Close
